Taysha Gene Therapies
TSHA
TSHA
108 hedge funds and large institutions have $402M invested in Taysha Gene Therapies in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 28 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+22
Holders Change %
+25.58%
% of All Funds
1.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
36
Increased
28
Reduced
27
Closed
14
Calls
$453K
Puts
$462K
Net Calls
-$9K
Net Calls Change
-$207K
Top Buyers
1 |
ACA
Avoro Capital Advisors
New York
|
$53.5M |
2 |
Morgan Stanley
New York
|
$14.8M |
3 |
OCA
Octagon Capital Advisors
New York
|
$8.7M |
4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
$5.08M |
5 |
RI
RTW Investments
New York
|
$53.4M |